In vivo fluorescence detection of ovarian cancer in the NuTu-19 epithelial ovarian cancer animal model using 5-aminolevulinic acid (ALA)

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 122-132

  Major, Attila L ^a,b   Scott Rose, G ^c   Chapman, Curtis F ^a   Hiserodt, John C ^c   Tromberg, Bruce J ^a   Krasieva, Tatiana B ^a   Tadir, Yona ^a   Haller, Urs ^b   Disaia, Philip J ^c   Berns, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LAPAROTOMY; METASTASIS; NONHUMAN; OVARY CANCER; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; ULTRAVIOLET RADIATION;

EID: 0031194375     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.4502     Document Type: Article

References (23)

1. Boring C. C., Squires T. S., Tong T., Montgomery S. Cancer statistics, 1994. Ca Cancer J. Clin. 44:1994;7-26.
2. P. J. DiSaia, W. T. Creasman, 1993, Epithelial Ovarian Cancer, Clinical gynecological oncology, 333, 425, Mosby-Year Book, St. Louis.
3. Moan J., Berg K. Photochemotherapy of cancer: Experimental research. Photochem. Photobiol. 55:1992;931-948.
4. Fisher A. M., Murphree A. L., Gomer C. J. Clinical and preclinical photodynamic therapy. Lasers Surg. Med. 17:1995;2-31.
5. Roberts W. S., Hodel K., Rich W. M., DiSaia P. J. Second-look laparotomy in the management of gynecologic malignancy. Gynecol. Oncol. 13:1982;345-355.
6. Friedman J. B., Weiss N. S. Second thoughts about second-look laparotomy in advanced ovarian cancer. N. Engl. J. Med. 322:1990;1079-1082.
7. J. S. Berek, H. F. Hacker, 1985, Staging and second-look operations in ovarian cancer, Ovarian cancer, D. S. AlbertsE. A. Survit, 109, 127, Martinus Nijhoff, Boston.
8. Kennedy J. C., Pottier R. H., Pross D. C. Photodynamic therapy with endogenous protoporphyrin IX: Basic principles and present clinical experience. J. Photochem. Photobiol. B. 6:1990;143-148.
9. von Rueden D., McBrearty F. X., Clements B. M., Woratyla S. Photo detection of carcinoma of the colon in a rat model: A pilot study. J. Surg. Oncol. 53:1993;43-46.
10. Steinbach P., Kriegmair P., Baumgartner R., Hofstadter F., Knuchel R. Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells. Urology. 44:1994;676-681.
11. Hua Z., Gibson S. L., Foster T. H., Hilf R. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res. 55:1995;1723-1731.
12. Kennedy J. C., Pottier R. H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B. 14:1992;275-292.
13. Van Hillegersberg R., Van den Berg J. W., Kort W. J., Terpstra O. T., Wilson J. H. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 103:1992;647-651.
14. Bedwell J., MacRobert A. J., Phillips D., Bown S. G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br. J. Cancer. 65:1992;818-824.
15. Rose S. G., Tocco L. M., Granger G. A., DiSaia P. J., Hamilton T. C., Santin A. D., Hiserodt J. C. Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am. J. Obstet. Gynecol. 1996.
16. Vaccarello L., Rubin S. C., Vlamis V., Wong G., Jones W. B., Lewis J. L., Hoskins W. J. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol. Oncol. 57:1995;61-65.
17. W. E. Grant, C. Hopper, A. J. MacRobert, P. M. Speight, S. G. Bown, Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolaevulinic acid, Lancet, 342, 147, 148.
18. Loh C. S., MacRobert A. J., Bedwell J., Regula J., Krasner N., Bown S. G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer. 68:1993;41-51.
19. Mlkvy P., Messmann H., Regula J., Conio M., Pauer M., Millson C. E., MacRobert A. J., Bown S. G. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX): A pilot study. Neoplasma. 42:1995;109-113.
20. Tochner Z., Mitchell J. B., Harrington F. S., Smith P., Russo D. T., Russo A. Treatment of murine intraperitoneal ovarian ascitic tumor with hematoporphyrin derivative and laser light. Cancer Res. 45:1985;2983-2987.
21. Sindelar W. F., DeLaney T. F., Tochner Z., Thomas G. F., Dachoswki L. J., Smith P. D., Friauf W. S., Cole J. W., Glatstein E. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Phase I study. Arch. Surg. 126:1991;318-324.
22. DeLaney T. F., Sindelar W. F., Tochner Z., Smith P. D., Friauf W. S., Thomas G., Dachowski L., Cole J. W., Steinberg S. M., Glatstein E. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;445-457.
23. Veenhuizen R. B., Ruevekamp H. M., Helmerhorst T. J., Kenemans P., Mooi W. J., Marijnissen J. P., Stewart F. A. Intraperitoneal photodynamic therapy in the rat: Comparison of toxicity profiles for photofrin and MTHPC. Int. J. Cancer. 59:1994;830-836.